DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

Osiris Therapeutics, Inc. (NASDAQ: OSIR)



company name or ticker

Athersys: Two Crucial Near-Term Events

Could PCT Be NeoStem's Breakout Star?

Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Resea

Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease

Vital Stem Cell Data And Development Coming In 2014

Surging Rank, Surging Stock: Why InSite Vision (INSV) is a Winner? - Tale of the Tape

Journal Publishes Grafix Clinical Study for Chronic Wounds

3 Ways 3-D Bioprinting Can Disrupt the Health-Care Industry

Will 3-D bioprinting technology from companies such as Organovo disrupt older technologies from Boston Scientific, Osiris Therapeutics, and Hanger?

MiMedx (MDXG) in Focus: Stock Moves 13.8% Higher - Tale of the Tape

Can Achillion Pharmaceuticals (ACHN) Continue to Surge? - Tale of the Tape

See More Articles...